Stroke prevention--insights from incoherence.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.The Cochrane database of systematic reviews · 2009
   Pooled it
2. Platelet function in stroke/transient ischemic attack patients treated with tocotrienol.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
   Trial
3. Antiplatelet Therapy After Noncardioembolic Stroke.Stroke · 2019
   Article
4. Comparison of antiplatelet regimens in secondary stroke prevention: a nationwide cohort study.BMC neurology · 2015
   Article
5. Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials.PloS one · 2012
   Article
6. Antiplatelet agents for stroke prevention.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2011
   Review
7. Understanding the PRoFESS Study for Secondary Stroke Prevention.Current treatment options in cardiovascular medicine · 2009
   Article

Corrections and comments

• Comment on
  Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.2008
• Comment on
  Telmisartan to prevent recurrent stroke and cardiovascular events.2008

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as